Characteristics of tummy time and dose-response relationships with development in infants

Zhiguang Zhang1, Madison Predy1, Kylie D Hesketh2

  • 1Faculty of Kinesiology, Sport, and Recreation, University of Alberta, Edmonton, AB, Canada.

Insights

Infants show increased tummy time preference and duration in the first six months. More tummy time is linked to better infant development, with optimal amounts increasing with age.

Area of Science:

  • Pediatric physical activity and developmental science.

Background:

  • Tummy time is a crucial physical activity for infant development.
  • Current guidelines recommend at least 30 minutes of daily tummy time for non-mobile infants.

Purpose of the Study:

  • To investigate changes in infant tummy time patterns and preferences during the first six months of life.
  • To examine the dose-response relationship between tummy time duration and infant developmental outcomes at 2, 4, and 6 months.

Main Methods:

  • Parental questionnaires assessed infant tummy time duration, preference, and development (Ages & Stages Questionnaire-3) at 2, 4, and 6 months.
  • A subsample used a 3-day time-use diary to measure tummy time bout frequency and length.
  • Participants were from the Early Movers project in Edmonton, Canada (n=411).

Main Results:

  • Tummy time bout frequency, bout length, and preference significantly increased over the first six months.
  • Linear dose-response relationships were found between tummy time duration and gross motor development at 4 months, and all developmental outcomes at 6 months.
  • Specific daily tummy time durations (e.g., 30-44 min/day at 2 months, 61-120 min/day at 6 months) were associated with higher total development scores.

Conclusions:

  • Infant preference for and engagement in tummy time increase during the first six months.
  • The optimal duration of tummy time for enhanced infant development appears to increase with age.
  • Findings suggest a dynamic relationship between tummy time and developmental progress in early infancy.

Related Concept Videos

Dose-Response Relationship: Overview01:03

Dose-Response Relationship: Overview

Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
3.3K
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.1K
Socioemotional Development during Infancy01:30

Socioemotional Development during Infancy

Socio-emotional development in infancy is primarily shaped by early emotional responses and social connections, with temperament playing a central role. Temperament refers to the consistent patterns in an individual's emotional and behavioral responses, observable even in infancy. By examining temperament, researchers can better understand an infant's unique ways of interacting with the world, influencing subsequent personality and socio-emotional growth.
Primary Temperament Types
91
Dose-Response Relationship: Potency and Efficacy01:22

Dose-Response Relationship: Potency and Efficacy

The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
4.8K